Patents by Inventor Virender Kumar

Virender Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120141525
    Abstract: The present invention relates to a novel influenza vaccine, a novel plasmid for preparing the same and a novel dosage form comprising the same. The present invention in particular relates to a recombinant modified vaccinia Ankara (MVA) virus comprising and capable of simultaneously expressing a cassette of at least four foreign genes from influenza virus, specifically an avian influenza virus, wherein the said genes are inserted at a non-essential site, within the MVA genome. The invention further relates to a recombinant modified vaccinia Ankara (MVA) virus comprising and capable of simultaneously expressing a cassette of not less than two foreign genes from influenza virus, wherein the said genes are inserted at a non-essential site, within the MVA genome, with the provision that at least one foreign gene is either PB2 or M2e. The invention also provides composition and methods of making the universal influenza vaccine.
    Type: Application
    Filed: May 17, 2010
    Publication date: June 7, 2012
    Applicant: PANACEA BIOTEC LIMITED
    Inventors: Rajesh Jain, Virender Kumar Vinayak, Nidhi Shukla, Neeraj Aggarwal, Rajan Mehta
  • Publication number: 20110269680
    Abstract: The present invention relates to a peptide selected from a group comprising GLP-1 analogs, its truncated forms, or pharmaceutically acceptable salts and derivatives thereof. The present invention further relates to a peptide selected from a group comprising GLP-1 analogs, its truncated forms, or pharmaceutically acceptable salts and derivatives thereof, wherein one or more aminoacids are substituted with a non-coded aminoacid.
    Type: Application
    Filed: December 24, 2009
    Publication date: November 3, 2011
    Applicant: PANACEA BIOTEC LIMITED
    Inventors: Rajesh Jain, Virender Kumar Vinayak, Sudhanand Prasad
  • Patent number: 7698435
    Abstract: A distributed service node includes a voice browser, media resources, such as automatic speech recognition (ASR) engines and text-to-speech (TTS) engines, and a resource manager. A media gateway converts between a pulse code modulation (PCM) format used in a circuit-switched telephone network and a real-time packet media format used by the distributed service node. A caller places a call to telephone number associated with the media gateway, and a real-time packet media session is established between the media gateway and the distributed service node. The voice browser queries a location server to determine the location of an interactive application associated with the called telephone number and then queries an application server corresponding to the location to obtain the interactive application as a voice extensible markup language (VXML) document. The browser interprets the VXML document and responsively invokes the media resources to provide an interactive media service to the caller.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: April 13, 2010
    Assignee: Sprint Spectrum L.P.
    Inventors: Thomas Paterik, Virender Kumar
  • Patent number: 7144863
    Abstract: The present invention encompasses compositions wherein a GLP-1 compound is complexed with a basic polypeptide. The compositions provide a prolonged duration of action and can be administered by the pulmonary route.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: December 5, 2006
    Assignee: Eli Lilly and Company
    Inventors: Michael Rosario DeFelippis, Henry Acken Havel, Kenneth F. Mace, Kingman Ng, Virender Kumar Sarin
  • Patent number: 6022955
    Abstract: This invention discloses a method for chemically modifying a pulmonary surfactant protein or polypeptides with various fatty acids. These conjugates are useful in preparing formulations for the treatment of respiratory disease.
    Type: Grant
    Filed: December 10, 1991
    Date of Patent: February 8, 2000
    Assignee: Abbott Laboratories
    Inventors: Virender Kumar Sarin, Darryl Robin Absolom, Shanker Lal Gupta
  • Patent number: 5753621
    Abstract: This invention discloses that certain fragments of a pulmonary surfactant protein exhibit unexpected surface activity. These protein fragments are useful in preparing formulations for the treatment of respiratory distress syndrome.
    Type: Grant
    Filed: May 4, 1995
    Date of Patent: May 19, 1998
    Assignee: Abbott Laboratories
    Inventors: Madhup Krishna Dhaon, Edwin Orville Lundell, Virender Kumar Sarin, Constance Hope Baxter, Darryl Robin Absolom
  • Patent number: 5700777
    Abstract: This invention discloses a method for chemically modifying a pulmonary surfactant protein or polypeptides with various fatty acids. These conjugates are useful in preparing formulations for the treatment of respiratory disease.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: December 23, 1997
    Assignee: Abbott Laboratories
    Inventors: Virender Kumar Sarin, Darryl Robin Absolom, Shanker Lal Gupta